Related by context. All words. (Click for frequent words.) 66 protein tyrosine phosphatase 1B 65 Cathepsin S 65 Dasatinib 64 selective modulator 64 Kinase Inhibitor 64 Cytochrome P# 64 glucokinase activator 64 LPA1 64 gastrin 64 Pathway Inhibitor 64 mGluR4 64 highly selective inhibitor 63 mTOR mammalian target 63 gamma secretase inhibitor 63 thalidomide Thalomid 63 hyaluronidase enzyme 63 immune modulating 63 Muraglitazar 63 Trandolapril 63 selective inhibition 63 inhibit metastasis 63 Factor VEGF 63 Deforolimus 63 Darapladib 63 mGluR2 NAM 63 Factor VIIa 63 Aliskiren 63 hypoxia inducible factor 62 Hypoxia Inducible Factor 62 Angiotensin converting enzyme 62 adenosine A2A 62 neuronal nicotinic receptors NNRs 62 glucagon receptor 62 Galectins 62 CCR9 62 Presents Preclinical Data 62 immune modulator 62 investigational humanized monoclonal antibody 62 leukotriene pathway 62 Bafetinib 62 JAK2 Inhibitor 62 thrombin receptor 62 specific lectin receptors 62 5 HT6 receptor 62 Squalamine 62 anti CD3 monoclonal 62 Clusterin 62 therapeutic monoclonal antibody 62 non nucleoside inhibitor 62 immunomodulatory properties 62 5 HT4 62 Aurora Kinase 61 mediated inhibition 61 PPARgamma 61 Anti Tumor 61 Wnt signaling pathway 61 A3 adenosine receptor 61 TRO# 61 kidney urologic 61 Drug Candidate 61 Tumour Vascular Disrupting Agent 61 PPARγ 61 COX2 61 Personalized Immunotherapy 61 Aviptadil 61 PKC# 61 cathepsin K inhibitor 61 peroxisome proliferator activated 61 apoptotic pathway 61 HQK 61 Systemic Delivery 61 Panzem R 61 Immunotherapeutic 61 MEK inhibitor 61 Recombinant Human 61 phosphatidylinositol 3 61 IL# PE#QQR 61 HSP# inhibitor 61 cMET 61 AEG# 61 endothelin receptor 61 Initiates Clinical 61 Bucindolol 61 NV1FGF 61 antiproliferative effects 61 multi kinase inhibitor 60 anti amnesic 60 Osteopontin 60 Estrogen Receptor 60 GVAX ® 60 Inflammatory Diseases 60 immunoregulatory 60 glycogen synthase kinase 60 CDDO Im 60 CYT# potent vascular disrupting 60 gastro intestinal inflammation 60 mertansine 60 HuMax TAC 60 Intravenous Human 60 DNA intercalator 60 HDL Selective Delipidation 60 Endothelin 60 multikinase inhibitor 60 RNAi Therapeutic 60 IMiDs R 60 HDAC Inhibitor 60 receptor tyrosine kinase inhibitor 60 c myc gene 60 proteasome inhibitor 60 SIRT2 60 IAP inhibitor 60 alpha#beta# integrin 60 Initiates Enrollment 60 Novel Oral 60 HDL Mimetic Peptide 60 Monoclonal antibody 60 Tezampanel 60 small molecule activator 60 angiogenesis inhibitor 60 mda 7 60 MAPK signaling pathway 60 R#/MEM # 60 PDE4 inhibitor 60 Metabolic Disease 60 TLR9 agonists 60 Cyclosporin 60 Kinase Inhibitors 60 Calcitonin 60 P#Y# [001] 60 Degarelix 60 GW# [003] 60 kinase PI3K 60 CTAP# Capsules 60 antisense inhibitor 60 Fibroblast Growth Factor Receptor 59 Darinaparsin 59 Trodusquemine MSI 59 ALN PCS 59 Epidermal Growth Factor Receptor 59 receptor inhibitor 59 AKT inhibitor 59 Maribavir 59 hyperphosphorylation 59 antisense inhibitors 59 targeted antifolate 59 PDE# 59 NNRs 59 demethylating agents 59 CCR2 59 depsipeptide 59 Inosine 59 YONDELIS 59 Posiphen TM 59 tubulin binding 59 OMP #R# 59 candidate deforolimus 59 Talabostat 59 Bazedoxifene 59 PF # [002] 59 humanized monoclonal 59 Safinamide 59 MGd 59 SERMs 59 cyclin dependent kinase inhibitor 59 anti CD3 59 thiazolides 59 CCR1 59 PNP inhibitor 59 histone deacetylase 59 Posiphen 59 Initiates Phase II 59 Small Molecule 59 Peptide YY 59 novel peptide 59 oral Janus kinase 59 Initiates Clinical Trial 59 PI3K/Akt pathway inhibitor 59 Investigational Compound 59 Angiolix 59 RNAi therapeutic targeting 59 Archexin 59 Romidepsin 59 acadesine 59 Silodosin 59 epothilones 59 immuno modulatory 59 PTP 1B 59 Initiates Phase III 59 potently inhibit 59 histone deacetylase inhibitor 59 Dendritic Cells 59 brivanib 59 Mucosal 59 ARRY # 59 2 methoxyestradiol 59 histone deacetylase HDAC 59 alpha#beta# 59 Epothilones 59 Tasimelteon 59 anti secretory 59 polysaccharide polymer 59 oncogenesis 59 oral prodrug 58 Protexia ® 58 Vidofludimus 58 PEG SN# 58 novel peptides 58 Neuroprotection 58 androgen receptor AR 58 targeted radiotherapeutic 58 HuLuc# 58 AAG geldanamycin analog 58 pan HDAC inhibitor 58 Anticancer Agent 58 gefitinib Iressa 58 JAK3 58 Albugon 58 GDIR 58 Tyrima 58 hedgehog pathway 58 forodesine 58 Sudhir Agrawal D.Phil 58 Romiplostim 58 cytochrome P 58 Hedgehog Pathway Inhibitor 58 Sphingomab 58 Novel Mechanism 58 Xcytrin R 58 immune modulatory 58 melanocortin receptor 58 IgG1 monoclonal antibody 58 midstage clinical 58 alpha 2A adrenergic 58 vascular disrupting agents 58 Cotara ® 58 Presents Preclinical 58 Vicriviroc 58 Autoimmunity 58 tubulin polymerization 58 Temsirolimus 58 RNA antagonists 58 Preclinical Study 58 CAMPATH 58 tubulin inhibitor 58 antibody MAb 58 immunotherapeutic vaccine 58 RhuDex 58 selective antagonist 58 naturally occurring molecule 58 ProMune 58 Parathyroid Hormone 58 Pafuramidine 58 histone deacetylase inhibitors 58 ThermoDox ® clinical 58 deCODE chemistry 58 mGlu2 3 58 nicotinic alpha 7 58 RNAi therapeutic targeting PCSK9 58 anticancer compound 58 Curaxin 58 SinuNase ™ 58 PSN# [002] 58 Monoclonal Antibody 58 regulating gene expression 58 JAK inhibitor 58 OMP #M# 58 ZK EPO 58 Nanobody 58 reversible inhibitors 58 novel therapeutic antibodies 58 Molecular Cancer 58 VEGF receptor 58 renin inhibitors 58 Phase 2b Trial 58 Epratuzumab 58 anti CD3 antibody 58 aurora kinase 58 small molecule agonists 58 pro angiogenic 58 Lodamin 58 small molecule Hedgehog 58 Symadex 58 PROGENSA R 58 NOX E# 58 Begins Dosing 58 Reverse Cholesterol Transport 58 Azacitidine 58 acetonide FA 57 A2 Lp PLA2 57 protein CETP 57 novel histone deacetylase 57 Cholestagel 57 imatinib Gleevec ® 57 receptor PPAR 57 immunoregulation 57 potent antiproliferative 57 Schisandrin B 57 Protease Inhibitor 57 FGFR 57 Trodusquemine 57 Nuclear Receptors 57 oral JAK1 57 5 HT2C serotonin 57 PI3 kinase inhibitors 57 eritoran 57 romazarit 57 nucleotide analog 57 Nanobody ® 57 chemokine receptors 57 Genasense ® oblimersen 57 antibody trastuzumab 57 B Raf 57 efaproxiral 57 BXT # 57 intranasal formulation 57 haematologic malignancies 57 kinase pathway 57 vidofludimus 57 potent cytotoxic 57 AMPA kainate 57 telomerase therapeutic 57 tumor angiogenesis 57 Ad5FGF 4 57 TACI Ig 57 neuroprotective properties 57 Receives Orphan Drug Designation 57 LY# [003] 57 oral ghrelin agonist 57 rhMBL 57 mediating pathological inflammation 57 phosphate S1P 57 alkylating agent 57 Fx #A 57 sphingosine kinase 57 selective immunoproteasome inhibitor 57 Vidaza R 57 antiangiogenic 57 Phase 2a Clinical Trial 57 Antiangiogenic 57 Vascugel 57 kallikrein 57 anti atherogenic 57 DNA hypermethylation 57 tiapamil 57 ATG Fresenius S 57 selective androgen receptor modulator 57 ALN TTR 57 Guanilib 57 Liprotamase 57 fosbretabulin 57 HER signaling pathway 57 erlotinib Tarceva 57 IMiD 57 compound perifosine 57 targets Galectin receptors 57 ADP receptor antagonist 57 microtubule inhibitor 57 MAGE A3 ASCI 57 Phase 2b Clinical Trial 57 metastatic colorectal 57 Curaxin CBLC# 56 cyclin dependent kinases 56 Nanobody R 56 Initiate Clinical Trial 56 cetuximab Erbitux 56 Pimavanserin 56 PDX pralatrexate 56 Successfully Completes Phase 56 epigenetic therapies 56 dasatinib Sprycel 56 Virulizin ® 56 TRAIL receptor antibodies 56 Six3 56 Varespladib 56 alagebrium 56 panitumumab Vectibix 56 biologic therapeutics 56 ATL/TV# 56 leukocyte adhesion 56 breast cancer metastasis 56 Vidaza azacitidine 56 ATL# [001] 56 ATL# [002] 56 Hodgkin lymphoma HL 56 BIM #A# 56 targeting PCSK9 56 Collaborators Publish 56 EP #R 56 mecamylamine 56 vascular disrupting agent 56 Metastatic Melanoma 56 apricitabine ATC 56 cardio renal 56 Reports Preclinical Data 56 HGS ETR2 56 Ceflatonin R 56 imatinib resistance 56 adecatumumab MT# 56 Cetrorelix 56 inhibitor rofecoxib 56 Announces Poster Presentations 56 ospemifene 56 5 Fluorouracil 56 Creabilis Therapeutics 56 TÎ ² 4 56 SGS# 56 thymosin beta 4 56 atacicept 56 adalimumab Humira 56 immunomodulatory effects 56 Sphingomab TM 56 triterpenoids 56 PROSTASCINT R 56 tyrosine kinase inhibitor 56 RenaZorb TM 56 lexidronam injection 56 psoriasis rheumatoid arthritis 56 Octreotide 56 3 kinase PI3K 56 Aflibercept 56 XYOTAX TM 56 lenalidomide Revlimid 56 VA# [002] 56 TOCOSOL 56 Aplidin R 56 FOLOTYN ® 56 TLR9 agonist 56 Spiegelmer 56 TLK# 55 PARP inhibitor 55 IV Busulfex 55 TOCOSOL Camptothecin 55 ON #.Na 55 Lpathomab 55 receptor blocker 55 vivo validation 55 immunotoxins 55 Ataluren 55 Zarnestra 55 BioNumerik 55 Biomarker Study 55 inhibitor SNRI 55 oral beclomethasone dipropionate 55 Panzem ® 55 ALK inhibitor 55 Panzem 55 epigenetic regulation 55 monocytes macrophages 55 phosphoinositide 3 55 CCR5 mAb 55 Dr. Bezprozvanny 55 Therapeutic Vaccine 55 Ozarelix 55 histone deacetylase HDAC inhibitors 55 Cloretazine 55 trastuzumab DM1 T DM1 55 Triolex 55 Angiocept 55 Elagolix 55 ArQule Kinase Inhibitor Platform 55 IGF IR 55 Factor Xa inhibitor 55 Aganocide 55 Velcade bortezomib 55 adult mesenchymal stem 55 BLP# Liposome Vaccine 55 VIRxSYS 55 CureDM 55 Afatinib 55 ImmuKnow R 55 nucleoside analogues 55 Caprospinol 55 targeted nucleotide prodrug 55 synthetic retinoid 55 mTOR inhibitor 55 Novel Small Molecule 55 Allogeneic 55 Angiogenesis 55 PARP inhibition 55 PDE# inhibitors 55 Cannabinoid 55 huC# DM4 55 investigational oral hepatitis C 55 Lenocta 55 molecular biomarkers 55 selective kinase inhibitor 55 angiogenesis inhibition 55 Hedgehog signaling pathway 55 Kamada AAT 55 Pyridorin TM 55 brivaracetam 55 cholesterol homeostasis 55 oral salmon calcitonin 55 Beta catenin pathway 55 Cyclooxygenase Inhibiting Nitric Oxide 55 EGFR HER2 55 sorafenib Nexavar 55 molecular determinants 55 selective androgen receptor modulators 55 humanized anti 55 Phase IIb clinical trials 55 ONCONASE R 55 chemopreventive agent 55 R#/MEM 55 myeloproliferative disorders 55 sphingosine 1 55 modulator SERM 55 Serdolect ® 55 JAK1 55 Omacetaxine 55 isoform selective 55 reslizumab 55 virus HCV protease inhibitor 55 Septin 9 55 Tß4 55 Trophos 55 Hedgehog antagonist 55 solithromycin 55 investigational oral anticoagulant 55 Tumor Angiogenesis 55 polycythemia vera PV 55 Tanespimycin 55 flavopiridol 55 Fenretinide 55 Phase 1b clinical trials 55 EVIZON TM 55 Omalizumab 55 antifibrotic 55 GPR# [002] 55 CINOD 55 chimeric antibody 54 induces apoptosis 54 Quark Biotech 54 SNT-MC#/idebenone 54 targeting CD# 54 PNT# 54 GPR# agonist 54 MyVax R 54 Catena ® 54 Anticancer Drug 54 developing Zerenex ferric 54 Onconase 54 Insegia 54 cilengitide 54 ELACYT 54 receptor partial agonist 54 IAP inhibitors 54 INCB# [001] 54 HCV polymerase inhibitors 54 menadione 54 Adenosine Therapeutics 54 CONBRIZA 54 PLK1 SNALP 54 molecularly targeted 54 SCIB1 54 CEQ# 54 bevacizumab Avastin ® 54 cisplatin resistant 54 oral mTOR inhibitor 54 Cancer Vaccines 54 Cand5 54 HDACi 54 Genaera Corporation 54 Inhalation Solution 54 Phase Ib Clinical Trial 54 inhibit KSP 54 preclinically 54 lucinactant 54 Annamycin 54 anti fibrotic 54 rALLy clinical trial 54 Oracea TM 54 miRagen 54 Elafin 54 delta isoform 54 anticancer agent 54 TTR gene 54 Virulizin R 54 MOG #-# 54 Humira adalimumab 54 Selective Electrochemical Tumor Ablation 54 AMD# [003] 54 Anavex #-# 54 alefacept 54 MyVax ® 54 Azedra 54 liprotamase 54 investigational hepatitis C 54 Zolinza 54 Androgen Receptor 54 antibody MT# 54 PANVAC VF 54 monoclonal antibody mAb 54 lymphatic vasculature 54 pancreatic colon 54 Potelligent Technology 54 Initiates Phase 2b 54 inhibits protein synthesis 54 Xyfid TM 54 mitogen activated ERK kinase 54 CD# monoclonal antibody 54 Enbrel etanercept 54 Pulmonary Arterial Hypertension 54 optimal dosing regimens 54 Cloretazine ® 54 DXL# 54 P#X# 54 organ transplant rejection 54 PRTX 54 ThermoDox R 54 Genistein 54 antimetastatic 54 allosteric modulation 54 Therapeutic Competitors companiesandmarkets.com adEgemonye 54 R roscovitine 54 otelixizumab 54 drug GAP #B# 54 RECOTHROM R 54 Civacir 54 #ME# 53 JAK Inhibitor 53 Amira Pharmaceuticals 53 anaplastic lymphoma kinase ALK 53 Novosom 53 Zybrestat 53 Abstract Accepted 53 Saegis Pharmaceuticals 53 Onco TCS 53 BiovaxID TM 53 receptor monoclonal antibody 53 estrogen receptor beta 53 malignant ascites 53 MEK inhibitor RDEA# 53 Androxal TM 53 compound CTCE 53 Viral Immunotherapy platform 53 Nexavar sorafenib 53 Maxy G# 53 Valortim TM 53 Treat Parkinson Disease 53 M2 subunit 53 Adenoma Prevention 53 MET VEGFR2 53 small molecule defensin 53 telomerase activation 53 Cethrin R 53 CMV vaccine 53 vaccine GRNVAC1 53 initiated Phase Ib 53 Liprostin 53 compound AEZS 53 Pim kinases 53 Aganocide ® 53 OXi# 53 Luteinizing Hormone Releasing Hormone 53 Kahalalide F 53 ISTODAX 53 radiation sensitizer 53 tolerogenic 53 Cardiomyocytes 53 mimetic compounds 53 HIV integrase inhibitor 53 candesartan cilexetil 53 BZL# 53 DAS# Fludase ® 53 Actimmune ® 53 GSK # 53 Myocet 53 Amrubicin 53 LibiGel ® 53 DiLA2 liposomes 53 lapatinib Tykerb 53 Intravenous CP 53 investigational therapies 53 EnVivo 53 SUVN 53 miRagen Therapeutics 53 KRN# 53 PXD# 53 GED aPC 53 LEP ETU 53 Cintredekin Besudotox 53 IRX 2 53 #:#-# [023] 52 phase III isavuconazole 52 rhLF 52 murine monoclonal antibody 52 centromere associated protein 52 cinacalcet HCl 52 chromium supplementation 52 Modrenal R 52 CBLC# 52 Oncogene 52 EGFR signaling 52 Ceflatonin ® 52 SMT C# 52 OHR/AVR# 52 NIC5 52 PrevOnco 52 histone deacetylase HDAC inhibitor 52 FoldRx Pharmaceuticals Inc. 52 OvaRex ® MAb 52 CB2 selective receptor agonist 52 Ophthotech 52 Initiate Phase 52 VivaGel ™ 52 Erbitux cetuximab 52 recurrent glioblastoma multiforme 52 SR B1 52 CRD5 52 Bleomycin 52 Genasense R oblimersen 52 factor VEGF 52 Davanat 52 cell lymphoma CTCL 52 seliciclib CYC# 52 Introgen ADVEXIN 52 Camptothecin 52 Inc. Nasdaq IMGN 52 Troxatyl 52 PhotoCure 52 compound ISA# 52 novel orally administered 52 HuMax HepC TM 52 Novel Anticancer 52 Cell Transplant 52 Eribulin 52 Familial Adenomatous Polyposis FAP 52 Exherin TM 52 Treanda bendamustine 52 MORAb 52 Yondelis ® 52 Neo Kidney Augment 52 Avicena 52 modulating cholesterol efflux 52 VitiGam 52 PhytoMedical 52 Sym# 52 Betaseron ® 52 Omthera 52 trastuzumab DM1 52 Manja Bouman CEO 52 Breast Cancer Assay 52 L BLP# 52 tkRNAi 52 SNS# T 52 Bryostatin 51 TRAIL receptors 51 Corixa Corporation 51 nonhuman primate model 51 3 carbinol 51 bioactive lipids 51 Sprycel dasatinib 51 Hedgehog pathway inhibitor 51 Vegenics 51 YONDELIS R 51 systemic RNAi therapeutic 51 EnVivo Pharmaceuticals 51 Apaziquone 51 Injectable Suspension 51 TYZEKA 51 TOCOSOL R 51 Bezielle 51 PCK# 51 Chronic Lymphocytic Leukemia CLL 51 Phase #b/#a clinical 51 J Nutr 51 CR# vcMMAE 51 telomerase inhibitors 51 OTCQB CTIX 51 Nasdaq OMER 51 Taligen Therapeutics 51 PhG alpha 1 51 davunetide intranasal AL 51 Cloretazine R 51 Neulasta R 51 Friedreich Ataxia FRDA 51 eniluracil 51 sodium Injection 51 Akebia Therapeutics 51 relapsed ALL 51 Reata Pharmaceuticals 51 verteporfin 51 Quark Biotech Inc. 51 Zenapax 51 lymphoid malignancies 51 Debio 51 Atiprimod 51 QUADRAMET R 51 Li Fraumeni 51 ACAPODENE R 51 parthenolide 51 ASCO GI 51 histamine dihydrochloride 51 phosphate receptor modulators 50 EZN 50 phase IIb clinical 50 Adult Stem Cell Therapy 50 novel anti infective 50 Camptosar ® irinotecan 50 Delipidation 50 HTS assay 50 zoledronic acid Zometa 50 vorinostat 50 AKIP TM 50 zanolimumab 50 cyclophilin inhibitors 50 Torisel temsirolimus 50 Agios Pharmaceuticals 50 deacetylase inhibitors 50 anti proliferative 50 motesanib diphosphate 50 Pyridorin 50 indibulin 50 Fujisawa Healthcare Inc. 50 Nasdaq ACHN 50 Chemoprevention 50 ZEVALIN ® 50 OTCBB CVBT 50 HepaSphere 50 drug ISA# 50 Fasudil 50 Forodesine 50 Somatuline 50 huN# DM1 50 Deferiprone 50 drug conjugate 50 immunotherapy treatments 50 IND submission 50 Elocalcitol 50 cardiac muscle contractility 50 GLP toxicology studies 50 telomerase inhibitor drug 50 Iressa gefitinib 50 Inc. Nasdaq ALNY 50 Nereus Pharmaceuticals 50 acamprosate prodrug 50 Rho proteins 50 agent bevasiranib 50 NASDAQ OMER 50 Valortim ® 50 LSE ASM 50 samarium Sm 50 olaparib 50 homotaurine 50 Arimidex anastrozole 50 Biological Therapy 50 Nasdaq NRGN 50 Proteo 50 Chemokine 50 lymphoproliferative diseases 50 Vectibix panitumumab 50 OTCBB CTIX 50 Removab 50 Vaccinex 50 Glypromate 50 Idiopathic Pulmonary Fibrosis 49 varespladib 49 cancer immunotherapies 49 inhibitor RG# 49 Exherin 49 NEUGENE R 49 ELND# 49 Thymosin beta 4 49 Inc. NASDAQ ORXE 49 Alimta pemetrexed 49 mapatumumab 49 Anticancer Agents 49 Huntexil 49 ART# 49 CINTREDEKIN BESUDOTOX 49 Busulfex 49 Bellicum Pharmaceuticals Inc. 49 ORE# 49 niche bioproducts 49 Mepact 49 OTCBB PYTO 49 Etubics 49 TRIMESTA 49 epigenomics 49 Dr. Dinarello 49 molecular pharmacologist 49 Prof. Gozes 49 CDK inhibitors 49 synapse maturation 49 candidate epratuzumab 49 HyACT 49 Theratope 49 Ascend Therapeutics 49 prophylactic vaccine 49 AQ4N 49 Nasdaq SCLN 49 oral leukoplakia 49 MIS# 49 immune modulation 49 pomalidomide 48 torezolid phosphate 48 AVN# [001] 48 AMEX RGN 48 Raptiva R 48 tramiprosate 48 ZYBRESTAT TM 48 Adherex Technologies 48 ZFP Therapeutic TM 48 velafermin belinostat 48 ranpirnase 48 HER2 antibody 48 cancer vaccine Norelin 48 Proxinium TM 48 Adrian Hobden Ph.D. 48 noscapine 48 FASEB J. 48 calmodulin kinase II 48 ibudilast 48 molecules peptides amino 48 Phase Ib clinical 48 Nasdaq SNSS 48 BiTE antibody MT# 48 DiaKine Therapeutics 48 Regado Biosciences 48 Sanofi aventis EURONEXT SAN 48 Cerimon 48 5' AMP 47 IRHs 47 GAP #B# 47 water dwelling cetaceans 47 proliferation apoptosis 47 Nasdaq MGRM 47 developer Antisoma plc 47 LUX Lung 47 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 47 rifalazil 47 Pixantrone BBR 47 Avastin bevacizumab 47 Acute Radiation Syndrome ARS 47 Alternext ALEHT 47 NASDAQ CXSP announced 47 oral RSD# 47 idiopathic pulmonary fibrosis IPF 47 Portola Pharmaceuticals 47 PolyMedix defensin 47 signal transduction pathway 47 LungExpress Dx TM 47 Medistem Laboratories 47 Epeius Biotechnologies Corporation 46 Eprodisate 46 MacroMed 46 FASgen 46 immunosuppressive 46 SR Pharma 46 PROVENGE sipuleucel T 46 compound COTI 46 Developmental Therapeutics Program 46 BIBW 46 Durata Therapeutics 46 Gastrointestinal Cancers Symposium 46 Chemokine Therapeutics 46 BioMarck 46 perifosine KRX 46 DISC1 46 PDL# 46 OTCBB AOLS 46 CTCE 46 Polycomb proteins 46 Cabrellis 46 biochemists biologists medical 46 DAVANAT ® 46 Clavis Pharma 46 pathogenesis 45 Antisense Pharma 45 REGENERX BIOPHARMACEUTICALS INC. 45 Massachusetts Biologic Laboratories 45 EGEN 45 AACR San Antonio 45 Nasdaq HALO 45 PRNewswire FirstCall Neurogen 45 Untested Matt Cassel 45 COPREXA ™ 45 Hh signaling 45 Argos Therapeutics 45 BRANFORD Conn. BUSINESS WIRE 45 habits Volkow 45 Aton Pharma Inc. 45 NASDAQ ALTH biopharmaceutical 45 Aphton Corporation 45 Syndax 45 Will Ferrell reprises 44 Endostar 44 James F. Pingpank 44 NASDAQ NRGN 44 tissue homeostasis 44 overactive receptor 44 Neurogen Corporation 44 5 HT6 antagonist 44 survival angiogenesis 44 Nasdaq GENR 44 Nasdaq ACEL 44 Vaccinogen 44 NASDAQ INGN